○Miho Emoto1, Hideo Sato-Akaba2, Hirotada Fujii3 (1.Department of Clinical Laboratory Science, School of Medical Technology, Health Sciences University of Hokkaido, 2.Department of Systems Innovation, Graduate School of Engineering Science, Osaka University, 3.Advanced Research Promotion Center, Health Sciences University of Hokkaido)
Session information
Oral
Oral
Contrast agents/Molecular/CEST
Sun. Sep 12, 2021 9:30 AM - 10:30 AM Room 5 (PACIFICO Yokohama North, 3F, G316+317)
Chairs: Masaya Takahashi(Department of Radiology, Juntendo University School of Medicine/Medical Affairs, Guerbet Japan), Syo Murata(Faculty of Health Sciences, Komazawa University.)
○Naoya Hayashi1,3, Junichi Hata1,2,3, Motoki Hirabayashi2, Sho Kurihara2, James, Hirotaka Okano2, Akira Furukawa1 (1.Department of Radiological Science, Tokyo Metropolitan University, 2.Jikei University School of Medicine, 3.RIKEN, Center for Brain Science)
○Fuminori Hyodo1, Elhelaly Abdelazim1, Yoshifumi Noda2, Norikazu Koyasu2, Ryota Iwasaki3, Hiroyuki Tomita4, Shinichi Shoda2, Hiroki Kato2, Takashi Mori3, Masayuki Matsuo2 (1.Department of Radiology Frontier Science For Imaging, Gifu University, 2.Department of Radiology, Gifu University, 3.Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 4.Department of Tumor Pathology, School of Medicine, Gifu University)
○Nobuhiro Nitta1, Hong Zhang1, Takuya Urushihata1, Hiroyuki Takuwa1, Manami Takahashi1, Tatsuya Higashi1, Kohsuke Kudou2, Takayuki Obata1 (1.National Institutes for Quantum and Radiological Science and Technology, 2.Department of Diagnostic Imaging, Hokkaido University Graduate School of Medicine)
○Matsumoto Yuki1, Masafumi Harada1, Yuki Kanazawa1, Mitsuharu Miyoshi2 (1.Institute of Biomedical Sciences, Tokushima University Graduate School, 2.GE Healthcare, Japan)
○Syo Murata1, Masaya Takahashi2,3, Shigeki Aoki2 (1.Department of Radiological Sciences, Komazawa University, 2.Department of Radiology, Juntendo University, 3.Guerbet Japan)